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Summory
Sect ion I  of  th is thesis-  Phormocology- focuses on the systemic ond renol
ef fects of  the speci f ic  renin inhibi tor  remikiren (Ro 42-5892) in hypertensive
pot ients wi th di f ferent degrees of  renol  funct ion impoirment.  l t  tests the
hypothesis ihoi  remikiren is on ef fect ive ont ihypertensive ogent wi th o fovoroble
renol  prof i le.  This wos the f i rst  study on the renol  ef fects of  on orol ly
odmin is te red  ren in  inh ib i to r  in  th is  to rge t  popu lo t ion .  In  sec t ion  l l -
Pothophysiology- ihe renin inhibi tor  is  used os o speci f ic  phormocologic tool  to
study the role of  the RAAS in the poihophysiology of  renol  sodium hondl ing in
pr imory hypertension. Since i t  is  not  feosible to meosure locol  introrenol  RMS-
oct iv i ty,  ihe response to remikiren wos used os o surrogote indicotor for  the stote
of octivotion of the RAAS. ln these studies we tested the hypothesis thot
dysregulot ion of  the ( introrenol)  RAAS, leoding to inoppropr iotely elevoted levels
of  the ef fector hormone ongiotensin l l ,  p loys ol  ro le in the impoired renol
sod ium hond l ing  ond obnormol  reno l  hemodynomics ,  e i ther  o r  no t  in  mutuo l
interoct ion,  in pr imory hypertension.
Chopter ' l  provides o generol  introduct ion,  reviewing doto thot  shows
primory hypertension to be o moin mediotor of  torget orgon domoge, such os
congest ive heqrt  fo i lure,  cerebro- ond per ipherol  vosculqr diseose ond chronic
renol  fo i lure.  The mult i foctor io l  pothogenesis of  pr imory hypertension ond i ts
seque loe  is  incomple te ly  unders tood.  Poss ib le  c lues  to  under ly ing  mechon isms
ore discussed, port iculor ly out l in ing the role of  the k idney os the ul t imote ef fector
orgon o f  sod ium-  ond vo lume homeostos is  ond thus  long te rm or te r io l  p ressure
regulot ion.  The pressure notr iuresis relot ionship is ossumed to ref lect  on intr insic
renol  property copoble of  mointoining long term blood pressure wi th in norrow
l imits by renol  perfusion pressure induced modulot ion of  sodium excret ion.  The
r ightword shi f t  of  ihe pressure notr iuresis reloi ionship in humon hypertension os
compored to  normotens ion ,  imp l ies  impo i rment  o f  reno l  sod ium hond l ing  in
hypertension. l ts precise noture ond pothophysiology is incompletely understood.
Apporent ly hypertensive pot ienis mointoin sodium homeostosis of  the cost of  on
elevoted blood pressure.  On top of  thot  q heierogenous blood pressure
response to shi f ts in dietory sol t  intoke hos been observed in these pot ients,
indicoi ing vor ioble sodium-sensi t iv i ty of  b lood pressure.  Sodium sensi t iv i ty hos
been ossocioted wi ih more severe torget orgon domoge. Ref in ing our
unders tond ing  o f  the  mechon ism o f  reno l  sod ium hond l ing  ond sod ium
sensi t iv i ty in pr imory hypertension moy thus hove importont impl icot ions for  our
thero peui ico I opprooch.
Our studies focused on the RAAS os this system ploys on importont role in the
pothogenesis of  hypertension, port iculor ly by i ts impoct on renol  sodium
hondl ing.  l t  is  ihe pr incipol  hormonol system thot modulotes both renol
hemodynomics,  i .e glomerulor f i l t rot ion rote ond renol  b lood f low, os wel l  os
tubulor funct ion ond thus of fecis renol  sodium hondl ing in both o direct  ond
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r ightword shi f t  of  the pressure notr iuresis relot ionship,  which subsequent ly
oppeored reversible dur ing RAAs-blockode. An overview of  the RrMS, including
i ts biochemistry ond the mult ip le oct ions of  the ef fector hormone ongiotensin l l
i n  humon phys io logy  ond po thophys io logy  is  g iven .  F ino l l y ,  we summor ized the
scope of  the thesis ond def ined our speci f ic  study quest ions.
Chopter two oddresses the different modes of intervention in the RAAS' renin
inhibi t ion,  ACE inhibi t ion ond ongiotensin l l  subtype 1 receptor blockode.
Potentiol differences in the mode of oction between these different closses of
drugs ore being discussed. The l i teroture on renin inhibi t ion is reviewed in more
detoi l ,  port iculor ly referr ing to the test  compound remikiren. This compound
induced blood pressure lowering ond dist inct  renol  ef fects in onimql
exper iments,  whereos the exper ience with orol ly oct ive renin inhibi tors in the
torget populot ion,  thot  is  humons with hypertension, is to dote st i l l  l imi ted.  No
doto is ovoi lqble on the renol  ef fects of  remikiren or ony other orol ly
odministered renin inhibi tor  in mon. Sect ion I  therefore fur ther explores the
phormocologicol  chorocter ist ics of  the renin inhibi tor  remikiren.
Sect ion l :  Phormocology
In chopter 3 we descr ibed the ef fects of  o s ingle orol  odministrot ion of  ó00 mg
remikiren in I  ó pot ients wi th essent io l  hypertension, who were on o moderotely
resir icted ietory sodium intoke. Remikiren induced o substont io l  fo l l  in meon
orter io l  pressure,  q lbei t  wi th o consideroble inter indiv iduol  vor iot ion,  which wos
not exploined by the vor ioble drug levels,  thus suggest ing thot remikiren exerts
i ts ef fect  moinly of  the t issue level .  Remikiren corrected the renol  vosoconstr ict ion
lhot usuol ly feotures pr imory hypertension. The glomerulor f i l t rot ion rote
remoined stoble,  whereos the ef fect ive renol  p losmo f low rose. As o
consequence f i l t rot ion f roct ion ond renol  vqsculor resistonce fel l ,  despi te the fq l l
in blood pressure,  suggest ing renol  vqsodi lot ion both ot  the level  of  the ef ferent
qnd of ferent or ler io le,  consistent wi th reduced formot ion of  ongiotensin l l .  Both
the systemic ond renol  hemodynomic ef fects were more pronounced in
indiv iduols wi th o higher in i t io l  immunoreoct ive renin,  presumobly reloted to the
indiv iduol  renin response to prevoi l ing sodium stotus os wel l  os the odoptot ion
to the supine posi t ion dur ing the study doys. The hemodynomic response wqs
olso more pronounced in pot ients wi th o greoter reoct ive r ise in immunoreqct ive
renin dur ing renin inhibi t ion,  considered to be due to interrupt ion of  the short
feedbock loop with ongiotensin l l ,  ond suggest ing,  ot  leost  in our short  term
sludy, thot  the r ise in renin,  which hos by some been considered o drowbock of
renin inhibi t ion,  does not counteroct  the remikiren induced hemodynomic
response, but insteod indicotes odequote net inhibi t ion of  the RAAS. The renol
effects of remikiren furthermore consisted of o rise in the frqctionol excretion of
sodium ond l i th ium, suggest ing o decreosed reobsorpt ion in the proximol
tubule.  Moreover,  we observed o decreose in ur inory olbumin excret ion.
ln chopter 4 we descr ibed the systemic ond renol  ef fects of  mult ip le dose
remikiren in essent io l  hypertensive pot ients wi th di f ferent degrees of  renol
| ) t , r * n l * r y  r s ; 1 s !  , ^  s ; r l r y a ,
function impoirment. The once-doily dose of ó00 mg of remikiren elicited RAAS
inhibition throughout the 24 hours. The observed dissociotion between o
sustoined ecreose in PRA ond o tronsient fol l  in ongiolensin l l  is in l ine with
previous studies using renin inhibitors. The peok drug levels immediotely ofter
dosing ond subsequent ropid cleoronce from lhe plosmo confirms the
phormocokinetic prof i le of remikiren, os described eorl ier. Animol experimentol
doto suggested ihot fhe kidrrey is the moin torget tissue for remikiren ond moy
provide o reservoir of drug within the body, o possible explonotion for the
sustqined phormocodynomic effects despite undetectoble plosmo drug levels.
Likely, in spite of the low orql bioqvqi lqbi l i ty, enough drug is ovoi loble ot the
torget level.  Renol function impoirment did nof cquse plosmo occumulotion of
the drug even in potients with o GFR os low os 20 mllmin. This is in occordqnce
with ropid biliory eliminotion of the drug, but does not rule out ihe possibility of
higher tissue concentrqtions in pofients with impoired renol function. Continued
treotment for eight doys with remikiren induced o foll in blood pressure thot wos
susloined fhroughout he doy, wifhout reflex tochycordio. The potients with renol
function impoirment showed o more pronounced blood pressure response thon
the essentiol hypertensives, despite similority in the systemic hormonol response.
Whether higher tissue levels of remikiren or o greoter contribufion of the RAAS to
vosomotor tone in lhese potients underly this difference is uncleor. Remikiren
induced o r ise in renql plosmo f low qnd o fol l  in renol vosculor resistonce,
thereby indicoting renol vosodilotot ion. Glomerulor f i l t rot ion rote wos
unchonged, resulting in o foll in filtrofion froction. Renql prolein excretion
decreosed during remikiren, not only in pofienfs with overt nephrotic ronge
proteinurio, but olso in the essenfiol hypertensives in whom olbuminurio fel l
significontly. Despite the lock of o control group or o recovery period, the
ontiproteinuric effect is likely to be genuine, considering the well-controlled study
conditions, ond well-estqblished stobilizotion of proteinurio before lhe onset of
freotment. Severol foctors moy occount for the ontiproteinuric effect, such os the
remikiren induced renol vosodilqtion, moinly locoted of the efferent orteriole,
which despite the fqll in blood pressure, couses o decreose in filtrotion pressure.
Moreover, the inhibition of other ongiotensin ll relofed intrqrenol effects, such os
mesongiol cell controction ond o decreose in filtrotion surfoce oreo moy hove
contributed to the ontiproteinuric effect of remikiren. Yet, our study design does
not ollow to conclude thot the ontiproteinuric effect is specificolly due to RMS-
blockode, os the lower blood pressure moy hove ployed o role os well .  Finol ly, o
net negotive sodium bolonce wos observed, with consideroble interindividuol
voriotion. No side effecfs were observed.
lmplicotions of the phormocology of remikiren
Whot ore the implicotions of our phormocologicol results? Firsf, remikiren, ol
leost during moderofely restricted ietory sodium intoke, is o potent ond well
toleroted ontihypertensive drug in hypertensive potients with different degrees of
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r to be sound
ond once ogoin corroborot ing the cruciol  involvement of  the RrMS in pr imory
hypertension. The more pronounced ef fect  on blood pressure in renol  fo i lure
potients is of interest ond deserves further study. Remikiren lowers blood
pressure both by inducing vosodi lot ion ond by foci l i tot ing notr iuresis,  os
indicoted both by the induced negot ive sodium bqlonce ond the shi f t  in the
pressure notr iuresis relot ionship.  (see sect ion two) Second, remikiren does not
compromize renol  funct ion os glomerulor f i l t rot ion role did not chonge.
However,  remikiren induced reduct ion in renol  funct ion moy wel l  occur in
condi t ions wi th impoirment of  renol  perfusion, such os hypovolemio,  renol  or tery
stenosis ond heort  fo i lure,  i .e c l in icol  s i tuot ions in which renol  funci ion cr i t icol ly
depends on prevoi l ing ongiotensin l l  levels.  Sodium deplet ion is wel l  known to
further enhonce this dependency. Third,  the obtoined reduct ion of  proteinur io
ond qlbuminur io suggests thqt  remikiren hos renoprotect ive propert ies.
Reduction of proteinurio is o consistent predictor of long term renoprotection,
both in diobet ic ond non-diobet ic pot ients.  Studies in diobetes suggest thot
reduct ion in olbumiur io is olso q morker of  renoprotect ion,  but for  the moment
this not estobl ished for non-diobet ic populot ions.  Fourth,  meosurement of
pretreotment circuloting components of the RrMS wos of l imited volue, of leost in
predict ing the long term hemodynomic ond renql  response to remikiren. Plosmo
renin oct iv i ly ,  the in i t iq l  immunoreqct ive renin ond the renin response to renin
inhibit ion, on the other hond, reflected most consistently the systemicol stote of
oct ivot ion of  the RAAS, os wel l  os the remikiren- induced ocute hemodynomic
response. Meosurements of  ongiotensin l l  showed conf l ic t ing resul ts,  o l though
we connot exclude under ly ing melhodologicol  fo l locies,  os the delerminot ion of
ongiotensin l l  is  nolor iously di f f icul t  ond subiect  to vor iobi l i ty .  However,  there is
olso increosing evidence thot t issue levels of  ongiotensin l l ,  rother thon plosmo
levels,  ore importont for  the phormocologicol  response to RAAS inhibi t ion.
Whether plosmo volues of the RAAS occurotely reflect the stote of octivotion ot
cr i t icol  t issue iorget s i tes is only hypothet icol .  Fi f th,  meosur ing drug levels did not
hove explonotory power os there wos no correlotion whotsoever to the
phormocodynomic responses. No occumulot ion of  remikiren occurred in
pot ients wi th renol  funct ion impoirment,  but  such could be the cose i f  t reotment
is prolonged.
Renin inhibi t ion versus other modes of  R,,AAS inhibi t ion
Could there be odvontoges of  renin inhibi t ion os compored to other modes
of RAAS blockode, such os ACE inhibi t ion or ongioiensin l l  receptor
oniogonism? As we did not moke o direct  comporison, we con not deduce from
our doto whether remikiren is in ony woy super ior  to,  or  d i f ferent f rom, these
other modes of  RAAS inhibi t ion.  Theoret icol ly i t  might be odvontogeous to block
the RAAS ot its f irst ond rote-l inrit ing step. In controst to the non-specific ACE-
inhibi tors,  which olso interfere in other systems such os the k in ins ond
prostoglondins,  renin inhibi tors qui te speci f icol ly inhibi t  the formot ion of
ongiotensin l l .  Moreover,  they olso prevent the formot ion of  ongiotensin l l  v io
non-ACE pothwoys. They inhibi t  ths RAA$ independent ly of  the presence ond
distr ibut ion of  ongiotensin l l  receptor subtypes. Lost ly,  they lock the reciprocol
r ise in ongiotensin l l thot occurs in response to ongiotensin l l receptor blockers,
of which the (polho)-physiologicol signif iconce is sf i l l  uncleor, but moy relote to
its vosodilotory effect hrough its effect on the ongiotensin ll type 2 receptor.
To dote, dofo from the l i terqture is st i l l  too l imited to drow f inql conclusions
on the theropeutic potenfiql of renin inhibitors in comporison io the qlternotive
RAAs-blockers. Systemicol ly odministered renin inhibitors induced both o more
ond o less pronounced lowering of blood pressure os compored to ACE
inhibitors, whereos the few orol ly ovoi loble renin inhibi lors oppeored to exert o
somewhot less pronounced blood pressure response, buf fhe implicotions of
these studies for fherqpeutics ore l imited due to fhe only brief durotion of
treolment ond relot ively smoll  study somples.
The renol effects of renin inhibitors oppeor ot leost promising ond deserve
more study. Animol experiments demonslroted substontiol renol vosodilot ion
due to renin inhibit ion. The renin inhibitors zonkiren ond enolkiren in heolthy
humqns induced signif icontly more pronounced renol vosodilot ion in direct
comporison with ACE inhibitors, suggesting thot prostoglondins or endothel iol
nitric oxide ore not involved in the response. lt hos been postuldted thot
introrenol conversion of ongiotensin I to ongiotensin ll occurs, of leost in port, ot
o site which is inqccessible fo ACE inhibit ion, or thot ihere moy be on olternotive
pothwoy for introrenol conversion thot is not blocked by ACE-inhibilion. Greoter
lipophilicity ond tissue penetrolion moy olso hove contributed to the more
pronounced renol hemodynomic response of renin inhibitors in these studies.
In our study, the fol l  in proteinurio with remikiren wos somewhot less thon
usuolly observed with ACE inhibition or AT, recepfor blockode. However, we
only treoted for eight doys, whereos it tokes opproximotely four weeks before the
moximum ontiproteinuric effect of ACEi ond AT, blockode is reoched. lt would
be of interest, therefore, to investigote whether more prolonged renin inhibition
would further reduce proteinurio. Moreover, it might be of interest to investigote
whether odditive theropy with renin inhibition could provide o strotegy to
circumvent treoiment resislonce to ACE-inhibition or AT, blockode by precluding
Íhe reoclive rise in renin octivity with those modes of R/MS blockode.
In conclusion, whereos the cl inicol oppl icot ion of renin inhibi lors hos thus fqr
been hompered by their poor bioovoi lobi l i ty, ond subsequently o less fovoroble
morketing profile, the dolo presented here suggest hot renin inhibition con be
cl inicol ly useful ond is moreover o specif ic tool to unrovel the mechonisms of
primory hypertension ond the renoprotective oction of RAAS blockode. In our
opinion i t  hos been too eorly to close renin inhibifor development progrommes,
ot leost from o phormocologicol stondpoint.
Section l l :  Pothophysiology
This section explores the role of ths R/AA$ in the pothophysiology of renol
sodium hondling in estobl ished hypertension. Renol hemodynomic
obnormoli t ies, both due fo structurol ond functionol chonges in the renol
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pot ients.  Chopter 5 covers the issue of  renol  hemodynomics in humon
hypertension. lmpoirment of  renol  b lood f low is common in pr imory
hyper lension. Renol  b lood f low is most ly decreosed, whereos glomerulor
fi l trotion rote remoins normol unti l odvonced hypertensive diseose. As o result,
renql  vosculor resistonce ond f i l t rot ion f roct ion is increosed. Findings in
normotensive of fspr ing suggest thot  renol  hemodynomic obnormol i t ies moy
precede hypertension ond ploy o cqusol  ro le.  On the other hond, renql
hemodynomic obnormol i t ies moy be o mqrker rother thon o mediotor of  renol
processes involved in the elevot ion of  b lood pressure.  In estqbl ished
hypertension obnormol renol  hemodynomics ossocioted with impoired renol
sodium hondl ing,  e i ther due to o pr imory defect  or  due to hypertensive renol
domoge, ore l ikely to ploy o role in the mointenonce of  h igh blood pressure.
Drugs blocking the RrMS improve both renol  b lood f low ond sodium hondl ing,
suggest ing thot RJMs-oct iv i ty is funct ionol ly involved in the renol  obnormol i t ies.
Hypertension is st i l l  o moior couse of  end-stoge renol  fo i lure,  ond importont ly,  o
treotoble one. Pothophysiologicol  ond epidemiologicol  f indings suggest the
presence of subgroups with on increosed risk for renol funclion loss. As o lower
torgei blood pressure moy be needed for odequote renoprotection, it would be
importont to identify high risk potients, to worront ogressive blood pressure
treotment in these suscepf ib le indiv iduols.  Moreover,  i t  would be importont fo
know whether blockode of specific pothophysiologicol pothwoys, such os fhe
RAAS, could exert protective effects in oddition to reduction of blood pressure.
Unrovel l ing of  the role of  fhe RAAS in renol  hemodynqmics ond renol  sodium
hondl ing ond i ts impoct on blood pressure in pot ients wi th pr imory hypertension
is complex for severol reosons. First, the stote of octivotion of ths R,AA$ of the
torget level ,  i .e wi th in the k idney, connot be direct ly meosured. Second, severol
introrenol  hemodynomic porometers wi th estobl ished pothophysiologicol
importonce in exper imentol  onimols ( i . " . ,  introrenol  b lood f low distr ibuf ion,
medul lory blood f low, introglomerulor hemodynomics,  ond heterogenei ty
between nephron populot ions) connot rel iobly be qssessed in mon ei fher.  Third,
other introrenol  neurohormonol systems moy oct  os confounding foctors.  Finol ly,
it is diff icult to discern couse ond effect, os oll involved porometers muluolly
interoct .  Speci f ic  b lockode of  the RAAS- os possible wi th renin inhibi t ion- could
be helpful  to unrovel  these complex in leroct ions.
In chopter ó we studied the pressure nqtr iuresis relot ionship by ossessing the
effect of spontoneous diurnol voriotions in blood pressure on sodium excretion
in untreoted primory hypertensive potients in bolqnce on o fixed sodium intoke,
thereby testing the efferent port of the renol feedbock loop. So for, studies on the
relot ionship between sodium ond blood pressure in mon olmost exclusively
oddressed blood pressure response to o chonge in sodium stoius,  i .e sodium
sensi t iv i ty of  b lood pressure.  Our opprooch, by invesl igot ing sponioneous
fluctuotions in blood pressure, olso circumvented the need for interventions in
blood pressure.  This is importont os meosures thot modify blood pressure in
mon ( i . "  infusion of  voso-pressor or -depressor ogents) usuol ly exert  d i rect
phormocologicol effects on sodium excretion os well. To test whefher RAAS
octivity l imits the efficocy of pressure notriuresis, we investigoled whether RAAS
blockode by remikiren could improve the pressure notr iuresis relof ionship.  Bofh
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before ond dur ing remikren treotmenl o normql diurnol  pot tern of  sodium
excretion ond blood pressure wos observed. During remikiren freotment the
diurnol  vqr iot ion in blood pressure correloted posi f ively wi th the vor iot ions in
sodium excret ion in ol l  pot ients,  whereos wifhout t reotment such o correlol ion
wqs presenf in only 3 out of 8 potients. The slope of the regression equotion wos
steeper dur ing remikiren in 7 ouf of  8 pot ients.  Thus, the relot ionship between
blood pressure ond notr iuresis wos more reodi ly opporent dur ing RAAS
blockode, suggesfing thot RAAS octivity blunts pressure nolriuresis in
hypertensive potients. This pothogenetic role of the RAAS is olso supported by
the foct thot- in ihe untreoted condition- the correlotion between blood pressure
ond sodium excretion wos strongest in the potients with the lowesf PRA level. Our
doto suggest thot resetting of the pressure notriuresis mechonism by remikiren
moy contribute to its blood pressure lowering oction. Whether the obsence of q
relot ionship between vqr iot ions in blood pressure ond sodium excret ion in the
untreoted condition is specific for essentiol hypertension con not be qscertoined
from our doto,  os th is would require o comporison with heol thy controls.
Severol  mechonisms could occount for  the impoct of  remikiren on pressure
notr iuresis.  Renol  vosodi lot ion con enhqnce the tronsmission of  chonges in renol
perfusion pressure to the per i tubulor qnd the medul lory microcirculot ion,  thus
tronsmitting blood pressure chonges to renol interstit iol pressure. The lotter is
presumed to mediote the notriurefic tubulor responses to elevqted renol
perfusion pressure. Since we did not study other renql vosodilotor ogents, we
connot dissociofe between the role of renol vosodilotion ond the role of reduced
ongiotensin l l  oct iv i ty os such. Finol ly,  we connot exclude lhot  remikiren
synchronized the diurnol  pot terns of  b lood pressure ond sodium excret ion by on
unident i f ied mechonism other thon enhqncement of  the blood pressure
dependency of notriuresis. Yet, combining our doto with those from the
litteroture suggests thqt the olterotions in pressure notriuresis in our study ore
likely to be due to RAAS blockode ond consequently reduced ongiotensin l l
effecls.
Other l ines of  evidence conf i rmed the importonce of  renql  hemodynomic
ol terof ions in sodium hondl ing by the k idney. Compese et  o l  demonstroted
increosed renol  vqsculor resistonce in soh-sensi t ive pof ients.  Hol lenberg et  o l
observed o blunted renol  vosodi lot ion to on increosed dietory sodium intoke in o
subpopulot ion of  pr imory hypertensives wi th concomitoni  impoirment of  renol
sodium hondl ing,  denoted os non-modulofors.  ApporenÍ ly,  h igh sodium intoke
unmqsks o pr imory disturbonce within the k idney, wi th on inoppropr iotely high
renol  vosculor tone dur ing high sodium. The ossocioted r ise in blood pressure
cqn be considered o compensotory response for the decreosed copocity of the
kidney to excrete sodium, in l ine with the principle of pressure nqtriuresis. Our
doto,  qs wel l  os fhose of  Hol lenberg,  suggest thot  inoppropr iote renol  RMS-
oct iv i ty is involved in th is obnormol odoplot ion to sodium.
Chopter 7, therefore, further explored the role of the RAAS in the renol
hemodynomic ond systemic odopfot ion to high dietory sodium. Our premise
wos thot o blunted renol  vqsculor response lo sodium, os on index of
inodequote suppression of  introrenol  ongiotensin l l  by high sodium, would be
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sodium, would be
lld expect o more
pronounced syslemic ond renol hemodynomic response to remikiren during
high sodium in subiects with on obnormol odoptotion to sodium. We tested this
hypothesis in potients with uncomplicoted estobl ished hypertension ond in
heolthy controls.
In the heolthy subiects high sodium intqke hod no effect on blood pressure or
body weight, whereos effective renol plosmo flow increosed ond immunoreoctive
renin decreosed signif icontly. In hypertensive subiects, high sodium intoke
induced o heterogeneous response of both blood pressure ond effective renol
plosmo f low. Body weight increosed ond immunoreoctive renin decreosed.
Interestingly, on increose in body weight ond o dist inct r ise in blood pressure
occurred only in those potients with o blunted response of renol plosmo flow to
the high sodium intoke, whereqs the lotter correloted well  with o less
pronounced fol l  in immunoreocfive r nin. The odoptotion of glomerulor f i l t rot ion
rote, ond consequently the f i l tered lood of sodium, wqs similor in subiects with o
sodium-resistont or o sodium-sensit ive blood pressure. Thus, in response to high
sodium, renol vosculor resistonce ond f i l t rot ion froct ion increosed only in
potients, in whom blood pressure rose os well .  This probobly indicotes both on
increosed preglomerulor ond postglomerulor vqsculor tone. The obsence of o
renol vosodilotor esponse to high sodium moy port ly be due fo structurol
obnormoli t ies of the renol vosculor bed, i .e hypedensive qrteriolor
nephrosclerosis. In occord with this ossumption, effecl ive renol plosmo f low wos
lower in the hypertensive potients, olreody during low sodium. Moreover,
effective renol plosmo flow wos lowesf in the oldest hypertensive potients. The
sodium-induced increose in flow, however, did not relote to oge. The observed
impoirment of renol blood flow, therefore, of leost to some extent, oppeors
functionol os olso suggested by the ossociofion with filtrotion froction.
Multiple regression demonstrofed thot rqce, sex, qge, or body weight did not
exploin the observed i f ferences in the blood pressure response to sodium. The
foct thot body weight increosed only in potients with o rise in blood pressure,
indicqtes thot volume exponsion, probobly due to impoired sodium excretion,
moy hove contributed to this rise.
During remikiren treotment we observed o heterogeneous response in renol
plosmo f low. Potients with o blunted renol plosmo f low response to high sodium
intoke showed the lorgest r ise in renol f low during remikiren. This shows the
reversibi l i ty of the impoired renol hemodynomic response to sodium, ond points
towqrds greoter renol RAAS octivity. The remikiren-induced rise in renol plosmo
flow correloted well  with the fol l  in blood pressure. Thus, the response to renin
inhibit ion shows thot insuff icient suppression of the renol RAAS impedes on
odequote renql vosculor esponse to high sodium, which is ossocioted with o
sodium-induced r ise in blood pressure. The correlot ion between the reduction in
renin ond renol vosodilot ion olso existed in o subgroup of our hypertensive
potients with renin levels thot were similor to those in the confrol group. This
refutes the ossumption by others thot renin is low ond of no impoct in solt
sensit ivi ty. In oddit ion, mult ivoriote onolysis in the normotensive subiects
demonstroted o correlot ion between lhe sodium-induced renin decreose ond
renol vosodilot ion when oge wos odded to the model. The observed voriot ion in
renin response could not be exploined by dif ferences in odherence to the diet.
Remorkobly, in both normotensive ond hypertensive subiects, the renin response
to sodium corresponded str ikingly with ihe reoctive r ise in renin induced by
remikiren. This sfrongly suggests thot the responsiveness of the RAAS to severol
dif ferent st imuli  s on individuol chorocterist ic.
Thus, odoptotion of the normol kidney to o high sodium is chorqcterized by o
rise in glomerulor f i l t rol ion rote ond effect ive renol plosmo f low, with unchonged
blood pressure. The RAAS is o modulolor of these renol hemodynomic honges.
In essentiol hypertension, o r ise in blood pressure in response to high sodium
intqke oppeors to result port iol ly from insuff icient renol vosodilot ion. Insuff icient
suppression of (possibly introrenql) RAAs-qctivity moy be involved, but the
precise level of disfurbonce remqins to be determined. Our doto primori ly
suggest dysregulotion within fhe kidney. Differences in responsiveness of the
renol vosculoture to prevoi l ing ongiotensin l l levels moy olso be involved. Further
studies on the locol stote of octivotion of the intqrenol RAAS ore needed to clorify
this issue.
In our next study we sought further evidence for our hypothesis thot
dysregulot ion of the introrenol RAAS ploys q role in the impoirment of renol
sodium hondling in esfobl ished hypertension, by ossessing the notr iuret ic
response to remikiren. We orgued thot increosed renol vosculor tone could be o
morker of R/Ms-medioted impoirment of renol sodium excretion. lf so, one
would expect thot RAAS blockqde would induce notriuresis in proportion to
pretreotment renol vosculor tone. This hypofhesis is tested in chopter 8, thot
describes the effects of remikiren on renol hemodynomics ond sodium excretion
in essentiol hypedensives, both qcutely ond ofter mult iple dosing, which ol lows
to estoblish the eventuol effect on sodium bolqnce. Preireotment renol vosculor
tone, os estimoted from filtrotion frqcfion ond renol vosculor resistonce, showed
consideroble individuol dif ferences. Remikiren induced o fol l  in blood pressure,
filtrotion frqction ond renql vosculor resistonce, with o consideroble
interindividuol voriobi l i ty in notr iuret ic response. The notr iuret ic response to
remikiren during single os well  os mult iple dose correlqted with pretreotment
renql vosculor tone, but not with remikiren-induced chonges in renol
hemodynomics or in hormonol poromefers. Cumulotive sodium loss wqs lorgest
in potients with o higher pretreotment fihrotion frqction ond renol vosculor
resistonce. Our f indings qre fhe f irst to demonstrote such o relot ionship.
In the multiple dose study pre-treolment ongiotensin ll correloted with
prelreotment renol vosculor esistqnce ond the remikiren-induced notr iuresis. On
the olher hond, correlotions between pretreotment PRA ond immunoreoctive
renin qnd the renol responses to renin inhibit ion, or between the remikiren-
induced chonges in hormonol porometers ond nofr iuresis were obsent in both
studies. Apporently our findings do not simply reflecf greoter R/Ms-octivity ond
consequently more pronounced effects of RAAS blockode ot oll porometers.
However, we connol exclude possible confounding effeds of methodologicol
fqctors in the ossessment of R/MS-components.
The notriuretic response did not correlote with the observed renol
vosodilot ion during remikiren, suggesting thof notr iuresis did not depend on
renol hemodynomic responses. However, renol hemodynomics were ossessed ol
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meqsurement. Thus, on oll-too-stroightforword conclusion connot be drown on
this issue. Moreover, olterotions in renol blood flow distribution con be presenl
with on unchonged effective renol plosmo flow: introrenol infusion of o low dose
ongiolensin ll con morkedly reduce medullory blood flow ond sodium excretion
without oltering whole-kidney blood flow. This roises fhe possibility thot in
potients with o higher pretreolment renol vosculor tone, remikiren induced o
relotively greoter increose in medullory blood flow, resulting in lorger notriuresis.
Whereos ossumptions on the introrenol mechonisms must remoin
speculotive, nevertheless, the consistent predidive volue of pretreotment renol
hemodynomics for notr iuresis during remikiren stonds out os o moin f inding.
The concordonce between the single ond multiple dose study supports its
robustness. The multiple dose doto, moreover, demonstrote thot the predictive
volue not only opplies to the ocute phormocologicol effects, but olso fo the finol
effect on sodium bolonce. As the lotter reflecls lhe net effect of phormocologicol
intervention ond counterregulotory homeostotic responses, we consider this o
better indicotor of the pothophysiologicol significonce of the observotion.
These findings suggest thot pretreotment renol vosculor resislonce ond
filtrotion froction indeed reflect inoppropriote introrenol RAAS octivity, resulting
in impoired sodium hondling, thot is unmosked by RAAS blockode. Studies from
Hollenbergs group support fhe ossociotion of elevoted renol vosculor resislonce
during high sodium with introrenol RAAS octivity in the subsei of essentiol
hypertensive potients denoted os non-modulotors. Whereos we did not ottempt
to delineqte subgroups, our doto ore consistent with inoppropriotely high
introrenol RAAS octivity in port of the hypertensive populotion.
We hove previously found on individuol response pottern of notriuresis for
ACE inhibit ion: our present f indings ore the f irst to l ink the individuol notr iuret ic
response to R/MS blockqde io individuol pre-treotment chorocteristics of renol
vosculor tone.
lmpoct of the pothophysiologicol studies
Whof could be the relevonce of our pothophysiologicol studies? Our sfudy of
the pressure notriuresis curye shows, first, thot onolysis of sponfoneous
fluctuotions cqn be succesfully opplied in studies on renol pothophysiology in
mon. This opprooch is onologous fo -for instonce- the onolyses of the
spontoneous voriobility in heort rote, o well estoblished porometer in
cordiovosculor reseqrch. lt ollows to study biologicol phenomeno without the
confounding effect of intervenfion, which ollows o more unbiosed oppreciotion
of the biologicol phenomeno of interest. This opprooch hos not previously been
opplied in humon renol physiology. Thus, our doto not only provide new insighfs
on the role of rhe RAAS in pressure notriuresis in humon hypertension, but olso
open up o new ongle for studies in renol (potho)-physiology in mon.
The studies in chopters 7 ond 8 both onolyse differences between individuol
potients with respect o R/Ms-medioted responses. These sfudies provide new
insights os to the role of the RAAS-medioted impoirment of renol sodium
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hond l ing  in  the  po thogenes is  o f  h igh  b lood pressure ,  showing tho t  some
indiv iduols,  chorocier ized by o high, RAAS-medioted, renol  vosculor tone, hove
inoppropr io te  sod ium re ien i ion  ond consequent ly  h igher  b lood pressure  dur ing
high sodium intoke. Moreover,  these doto show thot inter indiv iduol  d i f ferences
in responsiveness to RAAS blockode con be reloted to specific chqrocteristics of
the pot ients '  physiology, i .e to di f ferences in RAAS-physiology. Indiv iduol
differences in theropeutic benefit of RJMS blockode hove been noted to be
consideroble in recent studies in renol  pot ients ond in exper imentol  renol
diseose. Rotot ion schedules wi th di f ferent intervent ions showed thot
responsiveness io RAAS blockode is determined by indiv iduol  pot ient  foctors.
E luc ido t ion  o f  the  mechon isms under ly ing  these ind iv iduo l  d i f fe rences  in
responsiveness to RrMS blockode would be of  greot importonce to opi imize the
theropeeut ic benef i t .  Genet ic vor iobi l i ty  in ths RJAA$- i .e polymorphisms in the
genes coding for ACE ond for the ATI receptor-  os wel l  os interoct ion wi th
sodium os on environmentol  foctor moy be involved in the indiv iduol  d i f ferences
in responsiveness to RAAS blockode. Recent doto suggest thot  these
polymorphisms hove funci ionql  consequences for the RAAS phenotype. The
present studies under l ine ihe importonce of  phenotypic chorocter ist ics of  the
RAAS for the indiv iduol  d i f ferences in the response to RAAS blockode, ond
prompt for  studies in iegrot ing genotype-phenotype relot ionships os foctors
under ly ing indiv iduol  d i f ferences in theropy response.
